Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-12-12 Gelder Mark S. MD SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +45,000 45,000
2014-12-12 Drazba Brian G. VP, Finance & CFO Grant or award · Stock Option (Right to Buy) +35,000 35,000
2014-12-12 POYHONEN JOHN Director Grant or award · Stock Option (Right to Buy) +19,500 19,500
2014-12-12 MANHARD KIMBERLY Director Grant or award · Stock Option (Right to Buy) +19,000 19,000
2014-12-12 Johnson Craig A Director Grant or award · Stock Option (Right to Buy) +19,000 19,000
2014-12-12 DAVIS STEPHEN Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2014-10-31 Quart Barry D Chief Executive Officer Other acquisition +1,941 $7.50 $15K 63,796
2014-10-31 Drazba Brian G. VP, Finance & CFO Other acquisition +818 $7.50 $6K 818
2014-09-26 DAVIS STEPHEN Director Exercise or conversion +120,313 $7.20 $866K 122,710
2014-09-26 DAVIS STEPHEN Director Shares withheld for taxes −102,634 $8.44 $866K 20,076
2014-09-26 DAVIS STEPHEN Director Exercise or conversion · Stock Option (Right to Buy) −120,313 0
2014-09-03 DAVIS STEPHEN Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2014-06-25 TANG KEVIN C Director Purchase +510,638 $11.75 $6.0M 4,596,318
2014-06-25 Quart Barry D Chief Executive Officer Purchase +10,000 $11.75 $118K 61,855
2014-03-18 Gelder Mark S. MD SVP & Chief Medical Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2014-01-10 TANG KEVIN C Director Grant or award · Stock Option (right to buy) +29,500 29,500
2014-01-10 TANG KEVIN C Director Grant or award · Stock Option (right to buy) +27,750 27,750
2014-01-03 Quart Barry D Chief Executive Officer Grant or award · Stock Option (right to buy) −2,733,333 2,733,333
2014-01-03 Rosen Robert President Grant or award · Stock Option (right to buy) +3,400,000 3,400,000
2014-01-03 Gelder Mark S. MD SVP & Chief Medical Officer Grant or award · Stock Option (right to buy) +1,600,000 1,600,000

Page 39 of 45 · 881 trades